IRCT20240116060710N1
Recruiting
Phase 3
Evaluation the effect of Botulinum toxin type A Masport 500 injection on improving pain and quality of life in patients with diabetic neuropathy.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Definite diabetic neuropathy in the plantar area of ??both feet confirmed by NCV.
- •diabetes at least for three years
- •Consistency of the patient's medication for diabetic neuropathy for at least one month before entering the study
- •Filling out a personal consent form to enter the study
Exclusion Criteria
- •Having an underlying disease involving the peripheral nerves that causes symptoms similar to diabetic neuropathy in the plantar area.
- •Change in the patient's medication for diabetic neuropathy during at least one month before entering the study
- •History of myasthenia gravis
- •Allergy to botulinum toxin
- •kidney dysfunction
- •Having a history of alcohol consumption
- •Opioid addiction
- •Presence of pain with a typical dermatomal pattern caused by radiculopathy
- •Lack of patient consent to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disordersIRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34
Completed
Phase 2
Assessment of the botulinum toxin type A effect on Intensified Raynauds Phenomenon in Sclerodermic patientsSystemic sclerosis [scleroderma].Systemic sclerosis [scleroderma]IRCT20200106046023N1Oroumia University of Medical Sciences11
Active, Not Recruiting
Phase 4
To check wrinkle free forehead after injection of Botulinum drug.CTRI/2015/03/005613Dr L Krishna Prasad Head of department Department of oral and maxillofacial surgery
Not Yet Recruiting
N/A
Assessment of Botulinum Toxin Type A in the Treatment of Hand EczemaPACTR201704002194318Dermatology Department, Faculty of Medicine, University of Alexandria60
Completed
N/A
Analysis of efficacy of butulinum toxin type A treatment for compensatory hyperhidrosisCompensatory hyperhidrosisJPRN-UMIN000004254Department of Dermatology Aichi Medical University school of Medicine10